List of Excipients in API pioglitazone and metformin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing pioglitazone and metformin
Excipients in ANDA-approved (generic) drugs containing pioglitazone and metformin
Detailed excipient profiles for pioglitazone and metformin
Excipient focus: AMMONIA
pioglitazone and metformin drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | pioglitazone and metformin hydrochloride | 64764-510 |
| >Company | >Ingredient | >NDC |
pioglitazone and metformin drug variants not containing AMMONIA
Excipient focus: CANDELILLA WAX
pioglitazone and metformin drug variants containing CANDELILLA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | pioglitazone and metformin hydrochloride | 64764-510 |
| >Company | >Ingredient | >NDC |
pioglitazone and metformin drug variants not containing CANDELILLA WAX
Excipient focus: CELLULOSE ACETATE
pioglitazone and metformin drug variants containing CELLULOSE ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | pioglitazone and metformin hydrochloride | 64764-510 |
| >Company | >Ingredient | >NDC |
pioglitazone and metformin drug variants not containing CELLULOSE ACETATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
pioglitazone and metformin drug variants containing CELLULOSE, MICROCRYSTALLINE
pioglitazone and metformin drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | pioglitazone and metformin hydrochloride | 64764-510 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
pioglitazone and metformin drug variants containing CROSCARMELLOSE SODIUM
pioglitazone and metformin drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | pioglitazone and metformin hydrochloride | 64764-510 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
pioglitazone and metformin drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | pioglitazone and metformin hydrochloride | 64764-510 |
| >Company | >Ingredient | >NDC |
pioglitazone and metformin drug variants not containing FERRIC OXIDE RED
Excipient focus: HYDROXYPROPYL CELLULOSE
pioglitazone and metformin drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | pioglitazone and metformin | 0781-5626 |
| Cambridge Therapeutics Technologies LLC | pioglitazone and metformin | 70882-105 |
| Takeda Pharmaceuticals America Inc | pioglitazone and metformin hydrochloride | 64764-510 |
| >Company | >Ingredient | >NDC |
pioglitazone and metformin drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
pioglitazone and metformin drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | pioglitazone and metformin hydrochloride | 64764-510 |
| Bryant Ranch Prepack | pioglitazone and metformin hydrochloride | 71335-3019 |
| Bryant Ranch Prepack | pioglitazone and metformin hydrochloride | 71335-3020 |
| >Company | >Ingredient | >NDC |
pioglitazone and metformin drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
pioglitazone and metformin drug variants containing HYPROMELLOSE 2910
pioglitazone and metformin drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | pioglitazone and metformin hydrochloride | 64764-510 |
| Bryant Ranch Prepack | pioglitazone and metformin hydrochloride | 71335-3019 |
| Bryant Ranch Prepack | pioglitazone and metformin hydrochloride | 71335-3020 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
pioglitazone and metformin drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | pioglitazone and metformin hydrochloride | 64764-510 |
| >Company | >Ingredient | >NDC |
pioglitazone and metformin drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
pioglitazone and metformin drug variants containing MAGNESIUM STEARATE
pioglitazone and metformin drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
pioglitazone and metformin drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | pioglitazone and metformin hydrochloride | 71335-3019 |
| Bryant Ranch Prepack | pioglitazone and metformin hydrochloride | 71335-3020 |
| >Company | >Ingredient | >NDC |
pioglitazone and metformin drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
pioglitazone and metformin drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | pioglitazone and metformin hydrochloride | 64764-510 |
| >Company | >Ingredient | >NDC |
pioglitazone and metformin drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 6000
pioglitazone and metformin drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | pioglitazone and metformin | 0781-5626 |
| Cambridge Therapeutics Technologies LLC | pioglitazone and metformin | 70882-105 |
| >Company | >Ingredient | >NDC |
pioglitazone and metformin drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOL 8000
pioglitazone and metformin drug variants containing POLYETHYLENE GLYCOL 8000
pioglitazone and metformin drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POVIDONE
pioglitazone and metformin drug variants containing POVIDONE
pioglitazone and metformin drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | pioglitazone and metformin | 0781-5626 |
| Cambridge Therapeutics Technologies LLC | pioglitazone and metformin | 70882-105 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K25
pioglitazone and metformin drug variants containing POVIDONE K25
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | pioglitazone and metformin | 0781-5626 |
| Cambridge Therapeutics Technologies LLC | pioglitazone and metformin | 70882-105 |
| >Company | >Ingredient | >NDC |
pioglitazone and metformin drug variants not containing POVIDONE K25
Excipient focus: PROPYLENE GLYCOL
pioglitazone and metformin drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | pioglitazone and metformin hydrochloride | 64764-510 |
| >Company | >Ingredient | >NDC |
pioglitazone and metformin drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
pioglitazone and metformin drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | pioglitazone and metformin hydrochloride | 64764-510 |
| >Company | >Ingredient | >NDC |
pioglitazone and metformin drug variants not containing SHELLAC
Excipient focus: SODIUM LAURYL SULFATE
pioglitazone and metformin drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | pioglitazone and metformin hydrochloride | 64764-510 |
| >Company | >Ingredient | >NDC |
pioglitazone and metformin drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: TALC
pioglitazone and metformin drug variants containing TALC
pioglitazone and metformin drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | pioglitazone and metformin hydrochloride | 64764-510 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
pioglitazone and metformin drug variants containing TITANIUM DIOXIDE
pioglitazone and metformin drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
pioglitazone and metformin drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | pioglitazone and metformin hydrochloride | 64764-510 |
| >Company | >Ingredient | >NDC |
pioglitazone and metformin drug variants not containing TRIACETIN
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links